| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2006 | US7083634 Stabilized polyester/cyanoacrylate tissue adhesive formulation |
| 08/01/2006 | CA2395623C Inulin products with improved nutritional properties |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2375946C Pharmaceutical tablet and process for making thereof |
| 08/01/2006 | CA2360024C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 08/01/2006 | CA2340429C Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 08/01/2006 | CA2285407C Dosage forms comprising separate portions of r- and s-enantiomers |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 08/01/2006 | CA2274467C Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 08/01/2006 | CA2269217C New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives |
| 08/01/2006 | CA2255668C Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
| 08/01/2006 | CA2251194C Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| 08/01/2006 | CA2250714C Animal cells and processes for the replication of influenza viruses |
| 08/01/2006 | CA2245823C Farnesyl transferase inhibitors |
| 08/01/2006 | CA2236851C Substituted vinylpyridine derivatives and drugs containing the same |
| 08/01/2006 | CA2234611C New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 08/01/2006 | CA2198701C Substituted 9-alkyladenines |
| 08/01/2006 | CA2197867C Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 08/01/2006 | CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 08/01/2006 | CA2191855C Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/31/2006 | CA2493282A1 Method and composition for inhibiting cancer cell growth using urease and weakly basic anti-cancer compounds |
| 07/28/2006 | CA2497820A1 A cream formulation of steroid and diphenhydramine |
| 07/28/2006 | CA2494743A1 Flush niacin used as oral supplementation for treating withdrawal in a smoking cessation program |
| 07/27/2006 | WO2006079109A2 Non-toxic antimicrobial compositions and methods using pro-oxidative polyphenols and antioxidants |
| 07/27/2006 | WO2006079077A2 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 07/27/2006 | WO2006079057A2 Methods and compositions for specific inhibition of protein splicing by small molecules |
| 07/27/2006 | WO2006079021A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
| 07/27/2006 | WO2006079015A2 Quorum sensing modulators |
| 07/27/2006 | WO2006078992A2 Heteroaryl substituted piperazinyl-pyridine analogues |
| 07/27/2006 | WO2006078984A2 Uses of methylphenidate derivatives |
| 07/27/2006 | WO2006078948A2 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 07/27/2006 | WO2006078941A2 Novel sirtuin activating compounds and methods of use thereof |
| 07/27/2006 | WO2006078925A2 A tetracycline metal complex in a solid dosage form |
| 07/27/2006 | WO2006078907A1 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments |
| 07/27/2006 | WO2006078904A2 Use of tetrazole derivatives as quorum sensing modulators |
| 07/27/2006 | WO2006078903A1 Radiosensitizer formulations comprising nitrohistidine derivatives |
| 07/27/2006 | WO2006078891A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 07/27/2006 | WO2006078887A2 Methylphenidate derivatives and uses of them |
| 07/27/2006 | WO2006078886A2 Compounds and compositions as wnt signaling pathway modulators |
| 07/27/2006 | WO2006078876A2 Compositions and methods relating to mitochondrial hyperpolarization in neurological disease |
| 07/27/2006 | WO2006078875A2 A method for treating neurologic diseases |
| 07/27/2006 | WO2006078848A1 Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging |
| 07/27/2006 | WO2006078846A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/27/2006 | WO2006078842A1 Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction |
| 07/27/2006 | WO2006078834A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/27/2006 | WO2006078824A2 Eggshell membrane separation method |
| 07/27/2006 | WO2006078813A2 Arginine analogs, and methods for their synthesis and use |
| 07/27/2006 | WO2006078775A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | WO2006078754A1 Novel quinolinium salts and derivatives |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | WO2006078724A2 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 07/27/2006 | WO2006078713A2 Methotrexate combinations for treating inflammatory diseases |
| 07/27/2006 | WO2006078711A2 Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp |
| 07/27/2006 | WO2006078698A1 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases |
| 07/27/2006 | WO2006078697A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/27/2006 | WO2006078676A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/27/2006 | WO2006078659A2 Stable prostaglandin-containing compositions |
| 07/27/2006 | WO2006078636A1 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 07/27/2006 | WO2006078610A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy |
| 07/27/2006 | WO2006078606A2 Ati receptor antagonists for treating vascular inflammation |
| 07/27/2006 | WO2006078605A1 Methods of use of dual ppar agonist compounds and drug delivery devices containing such compounds |
| 07/27/2006 | WO2006078600A1 Compositions containing policosanol and theaflavin and their pharmaceutical uses |
| 07/27/2006 | WO2006078598A2 Mitotic kinesin inhibitors |
| 07/27/2006 | WO2006078593A2 Direct compression formulation and process |
| 07/27/2006 | WO2006078577A1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease |
| 07/27/2006 | WO2006078576A2 Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/27/2006 | WO2006078575A2 Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins |
| 07/27/2006 | WO2006078574A2 Mitotic kinesin inhibitors |
| 07/27/2006 | WO2006078554A2 Cgrp receptor antagonists |
| 07/27/2006 | WO2006078524A1 Methods for qt interval control |
| 07/27/2006 | WO2006078458A1 Tamponade compositions and methods for retinal repair |
| 07/27/2006 | WO2006078457A2 Use of resolvins to treat gastrointestinal diseases |
| 07/27/2006 | WO2006078450A1 9a, 11-2c-bicyclic 9a-azalide derivatives |
| 07/27/2006 | WO2006078422A2 Methods for modulating tumor growth and metastasis |
| 07/27/2006 | WO2006078384A2 Stilbene derivatives and their use |
| 07/27/2006 | WO2006078331A2 Crystallization via high-shear transformation |
| 07/27/2006 | WO2006078320A2 Methods for manufacturing delivery devices and devices thereof |
| 07/27/2006 | WO2006078317A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/27/2006 | WO2006078287A2 Pde4b inhibitors and uses therefor |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006078277A2 Dalbavancin compositions for treatment of bacterial infections |
| 07/27/2006 | WO2006078257A1 Substituted fullerene compositions and their use in treatment of shock |
| 07/27/2006 | WO2006078253A1 Method of reclaiming drug compound osi-7904 from liposomal drug manufacturing stream |
| 07/27/2006 | WO2006078211A1 Growth factor composition |
| 07/27/2006 | WO2006078066A1 Transbronchial remedy for respiratory infection |
| 07/27/2006 | WO2006078056A1 Drugs for activating muscle satellite cell |
| 07/27/2006 | WO2006078037A1 Process for producing thiazolidinedione compound and production intermediate thereof |
| 07/27/2006 | WO2006078032A1 Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative |
| 07/27/2006 | WO2006078006A1 Indole compound and pharmaceutical composition containing the same |
| 07/27/2006 | WO2006077984A1 Fluoroalkylpyrrolidine derivative |
| 07/27/2006 | WO2006077975A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077972A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077954A1 Remedy for neurological disease |
| 07/27/2006 | WO2006077901A1 Ctgf expression inhibitor |
| 07/27/2006 | WO2006077856A1 Injection for mastitis |